Cel-Sci Corp. (CVM)

07:08 AM

What moving averages say about CEL SCI CorporationChart-Based Entry Confirmation for Beginners - Newser

07:08 AM

12:37 PM

Is CEL SCI Corporation a good long term investmentAchieve breakthrough financial results today - jammulinksnews.com

12:37 PM

Jul 30, 2025

What makes CEL SCI Corporation stock price move sharply7-Day Equity Return Range Forecast Model - Newser

Jul 30, 2025

Jul 30, 2025

Is CEL SCI Corporation stock poised for growthPredictable Return Plan with Entry Guidance - Newser

Jul 30, 2025

Jul 30, 2025

Is CEL SCI Corporation stock entering bullish territoryTechnical Confirmation System with Signal Alerts - Newser

Jul 30, 2025

Jul 29, 2025

SRCE names Andrea G. Short CEO; founder shifts to Executive Chairman | CVM SEC FilingForm 4 - Stock Titan

Jul 29, 2025

Jul 29, 2025

How did CVM's operating expenses trend in Q1 2025? - AInvest

Jul 29, 2025

Jul 28, 2025

CEL-SCI Corp Insider Buying: CEO Geert Kersten Acquires Additional Shares - AInvest

Jul 28, 2025

Jul 28, 2025

Trading Halted for CVM Amidst Volatility Pause - AInvest

Jul 28, 2025

Jul 28, 2025

CEL-SCI Corporation Stock (CVM) Opinions on $5.7 Million Offering Announcement - Quiver Quantitative

Jul 28, 2025

Jul 28, 2025

Cel-Sci Corp (CVM) Stock: A Year of Declines and Increases - investchronicle.com

Jul 28, 2025

Jul 28, 2025

Price momentum metrics for CEL SCI Corporation explainedTechnical Entry Plan with Risk Minimization - Newser

Jul 28, 2025

Jul 28, 2025

Is CEL SCI Corporation stock poised for growth Free Daily Growth Stock Pick Reports - Newser

Jul 28, 2025

Jul 28, 2025

Should I hold or sell CEL SCI Corporation stock in 2025Unlock exclusive stock market forecasts - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Does CEL SCI Corporation stock perform well during market downturnsBuild wealth with long-term growth strategies - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

What is the risk reward ratio of investing in CEL SCI Corporation stockMaximize your gains with expert trading tips - jammulinksnews.com

Jul 28, 2025

Jul 27, 2025

How strong is CEL SCI Corporation company’s balance sheetCapitalize on market momentum for maximum gains - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

What institutional investors are buying CEL SCI Corporation stockAchieve consistent profits with disciplined trading - jammulinksnews.com

Jul 27, 2025

Jul 25, 2025

What analysts say about CEL SCI Corporation stockConsistent double returns - PrintWeekIndia

Jul 25, 2025

Jul 23, 2025

CEL SCI Corporation Stock Analysis and ForecastFree Stock Selection - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What drives CEL SCI Corporation stock priceFree Stock Market Real-Time Monitoring - jammulinksnews.com

Jul 22, 2025

Jul 18, 2025

Is CEL SCI Corporation stock a growth or value playBreakout Setup Scanner - Newser

Jul 18, 2025

Jul 17, 2025

CVM’s Market Whiplash: -89.97% YTD Decline, 71.11% Rise in 30 Days - investchronicle.com

Jul 17, 2025

Jul 15, 2025

How CEL SCI Corporation stock performs during market volatilityRapid Gain Targets - Newser

Jul 15, 2025

Jul 15, 2025

Why CEL SCI Corporation stock attracts strong analyst attentionLow Risk Trade Timing Signals - Newser

Jul 15, 2025

Jul 15, 2025

NKGen Biotech (NYSE:NKGN) versus CEL-SCI (NYSE:CVM) Head-To-Head Comparison - Defense World

Jul 15, 2025

Jul 14, 2025

CEL-SCI Closes $5.7 Million Stock Offering - MarketScreener

Jul 14, 2025

Jul 14, 2025

CEL-SCI raises $5.7 million in at-market offering of common stock - Investing.com

Jul 14, 2025

Jul 14, 2025

CEL-SCI Secures $5.7M Funding Boost: What This Means for Their Cancer Immunotherapy Pipeline - Stock Titan

Jul 14, 2025

Jul 14, 2025

Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Jul 14, 2025

Jul 12, 2025

CEL-SCI's $5.7M Stock Offering: A Lifeline for Multikine or a Signal of Strained Viability? - AInvest

Jul 12, 2025

Jul 11, 2025

Cel-Sci announces pricing of $5.7 million offering - MarketScreener

Jul 11, 2025

Jul 11, 2025

CEL-SCI Stock Soars On Imminent Partnership With Saudi Arabian Pharma Company For Cancer Drug: Retail’s Thrilled - NewsBreak: Local News & Alerts

Jul 11, 2025

Jul 11, 2025

CEL-SCI prices $5.7 million common stock offering at $3.82 per share By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

CEL-SCI prices $5.7 million common stock offering at $3.82 per share - Investing.com

Jul 11, 2025

Jul 11, 2025

Cel-Sci Corp (AMEX: CVM) – Does It Provide Stability And Growth? - Stocksregister

Jul 11, 2025

Jul 11, 2025

CEL-SCI partners with Saudi pharmaceutical firm to bring Multikine to market By Investing.com - Investing.com South Africa

Jul 11, 2025

Jul 11, 2025

CEL-SCI stock soars after Saudi partnership for cancer drug Multikine - Investing.com Canada

Jul 11, 2025

Jul 11, 2025

CEL-SCI partners with Saudi pharmaceutical firm to bring Multikine to market - Investing.com Canada

Jul 11, 2025

Jul 11, 2025

CEL-SCI to Sign Partnership Agreement With Leading Saudi Arabian Pharma Company for Multikine in the Treatment of Head & Neck Cancer - Yahoo Finance

Jul 11, 2025

Jul 11, 2025

3 AI-Driven Medical Device Stocks to Watch in 2025 - The Globe and Mail

Jul 11, 2025

Jul 11, 2025

DeFi Dev Corp. and Switchboard Join Forces to Advance RWA Oracle Infrastructure on Solana - The Globe and Mail

Jul 11, 2025

Jun 18, 2025

CEL-SCI applauds FDA approval of Merck’s Keytruda for head and neck cancer - Investing.com Canada

Jun 18, 2025

Jun 18, 2025

FDA’s Approval of Keytruda for PD-L1 Positive Head and Neck Cancer Patients Signals a Clear Pathway for CEL-SCI’s Multikine to Address a Major Unmet Need in PD-L1 Negative Cancer Patients - Yahoo Finance

Jun 18, 2025